Vytas Reipa

Dr. Vytas Reipa

Biosystems and Biomaterials Division, National Institute of Standards and Technology, 100 Bureau Dr., Gaithersburg, MD, USA
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2017 in Nanoscale
Verified
Journal Article
Closed access
PDF file
CSChristopher Sims
Christopher Sims
SHShannon K. Hanna
Shannon K. Hanna
DHDaniel A. Heller
Daniel A. Heller
CHChristopher P. Horoszko
Christopher P. Horoszko
MJMonique Johnson
Monique Johnson
BNBryant C. Nelson
Bryant C. Nelson
Nanomedicine utilizes the remarkable properties of nanomaterials for the diagnosis, treatment, and prevention of disease.

16 June 2009 in Langmuir
Verified
Journal Article
Closed access
JCJonghoon Choi
Jonghoon Choi
NWNam Sun Wang
Nam Sun Wang
VRVytas Reipa
Vytas Reipa

29 January 2002 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
VRVytas Reipa
Vytas Reipa
MMMartin P. Mayhew
Martin P. Mayhew
MHMarcia J. Holden
Marcia J. Holden
VVVincent L. Vilker
Vincent L. Vilker
Spectroelectrochemistry measurements are used to demonstrate that active site mutation and binding of an non-natural substrate to P450cam (CYP101) reduces the shift in the redox potential caused by substrate-binding, and thereby results in slower catalytic turnover rate relative to wild-type enzyme with the natural camphor substrate.

28 July 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
IKIn Young Kim
In Young Kim
TLTae Geol Lee
Tae Geol Lee
VRVytas Reipa
Vytas Reipa
MHMin Beom Heo
Min Beom Heo
Titanium dioxide nanoparticles (TiO2 NPs) have wide commercial applications, owing to their small size; however, the biosafety of TiO2 NPs should be evaluated further. In this study, we aimed to investigate the cytotoxicity of TiO2 NPs in the presence and absence of ultraviolet A (UVA) irradiation in human keratinocyte HaCaT cells. TiO2 NPs did not significantly affect cell viability in the absence of UVA irradiation. Nonetheless, UVA-irradiated TiO2 NPs induced caspase-dependent apoptosis of HaCaT cells. Exposure of HaCaT cells to TiO2 NPs and UVA resulted in reactive oxygen species (ROS) generation and lysosomal membrane permeabilization (LMP); both effects were not observed in the absence of UVA irradiation. An analysis of the relationship between LMP and ROS, using CA-074 as a cathepsin inhibitor or NAC as an antioxidant, showed that LMP stimulates ROS generation under these conditions. These results imply that LMP-dependent oxidative stress plays a critical role in the UVA phototoxicity of TiO2 NPs in HaCaT cells.

1 January 1996 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
DADonald H. Atha
Donald H. Atha
AGAdolfas K. Gaigalas
Adolfas K. Gaigalas
VRVytas Reipa
Vytas Reipa
The Raman spectra of commercially available heparin disaccharide standards exhibit bands associated with the N-sulfate and the 6-O-sulfate groups of the glucosamine and the 2-O-sulfate of the iduronic acid. The N-sulfate has a strong band at 1039 cm-1. The 6-O-sulfate and the 2-O-sulfate exhibit bands at 1055 and 1065 cm-1, respectively. The pattern of these modes, which are assigned to the symmetric SO3 vibrations, was supported by semiempirical quantum mechanical calculations. The above bands were identified in the Raman spectrum of a commercial preparation of porcine mucosal heparin and were used to determine the relative proportion of the N-sulfate, 6-O-sulfate, and 2-O-sulfate groups in the heparin molecule. This information, which is complementary to that obtained by NMR spectroscopy, is of particular importance in relation to biological activity. This study also extends the usefulness of Raman spectroscopy to include structural details required for the quality assurance of pharmaceutical preparations of heparin.

29 November 2013 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SRSteve Y. Rhieu
Steve Y. Rhieu
AUAaron A. Urbas
Aaron A. Urbas
DBDaniel Bearden
Daniel Bearden
JMJohn P. Marino
John P. Marino
KLKatrice A. Lippa
Katrice A. Lippa
VRVytas Reipa
Vytas Reipa